FY2026 Earnings Forecast for Albemarle Issued By Scotiabank

Albemarle Corporation (NYSE:ALB) – Analysts at Scotiabank issued their FY2026 earnings per share (EPS) estimates for Albemarle in a research report issued on Monday, November 2nd. Scotiabank analyst B. Isaacson forecasts that the specialty chemicals company will earn $11.64 per share for the year. Scotiabank has a “Sector Outperform” rating and a $190.00 price target on the stock. The consensus estimate for Albemarle’s current full-year earnings is $11.15 per share. Scotiabank also issued estimates for Albemarle’s FY2027 earnings at $14.15 EPS.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.05. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.52 billion. Albemarle had a return on equity of 15.23% and a net margin of 10.40%. The business’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.19) EPS.

Several other equities analysts have also weighed in on ALB. Mizuho raised Albemarle from a “neutral” rating to an “outperform” rating and set a $130.00 price objective on the stock in a research note on Wednesday, October 14th. Argus dropped their target price on shares of Albemarle from $230.00 to $135.00 and set a “buy” rating for the company in a research report on Wednesday, October 7th. Citigroup cut their price target on shares of Albemarle from $175.00 to $125.00 and set a “buy” rating on the stock in a report on Thursday, October 22nd. Royal Bank Of Canada reduced their price target on shares of Albemarle from $157.00 to $129.00 and set an “outperform” rating on the stock in a research report on Thursday, October 15th. Finally, Morgan Stanley reiterated a “reduce” rating and set a $161.00 price objective on shares of Albemarle in a research note on Monday, August 10th. Fifteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $179.41.

Albemarle Stock Performance

Shares of NYSE:ALB opened at $98.25 on Friday. The business has a 50-day moving average of $108.33 and a two-hundred day moving average of $148.24. The firm has a market capitalization of $11.59 billion, a PE ratio of 23.73, a P/E/G ratio of 0.57 and a beta of 1.34. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.09 and a quick ratio of 1.35. Albemarle has a 12 month low of $89.77 and a 12 month high of $221.00.

Institutional Investors Weigh In On Albemarle

Several institutional investors and hedge funds have recently modified their holdings of ALB. Wellington Management Group LLP raised its holdings in shares of Albemarle by 161.8% during the 2nd quarter. Wellington Management Group LLP now owns 49,412 shares of the specialty chemicals company’s stock valued at $6,672,000 after buying an additional 30,541 shares during the period. Great Lakes Advisors LLC purchased a new position in Albemarle in the 2nd quarter worth approximately $4,246,000. NFJ Investment Group LLC purchased a new position in Albemarle in the 2nd quarter worth approximately $23,328,000. WINTON GROUP Ltd acquired a new stake in Albemarle in the second quarter valued at approximately $4,145,000. Finally, Meiji Yasuda Asset Management Co Ltd. acquired a new stake in Albemarle in the second quarter valued at approximately $2,012,000. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be paid a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, December 18th. Albemarle’s payout ratio is currently 39.61%.

Key Stories Impacting Albemarle

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Albemarle reported Q3 adjusted earnings of $2.58 per share, ahead of analyst estimates, and revenue of $1.55 billion, also above expectations and up 18.8% year over year. Higher lithium prices drove a sharp profit increase and stronger cash flow, supporting the positive investor case. Read More. · Read More.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.